(Q27687671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

4-Acyl pyrroles: mimicking acetylated lysines in histone code reading (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Xavier Lucas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Stefan Gerhardt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Manfred Jung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

4

Karin Schmidtkunz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

6

Roland Schüle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Daniel Wohlwend

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Martin Hügle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Stefan Günther

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

24 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

Angewandte Chemie International Edition

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

14055-14059

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

Chromatin modifications and their function

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Histone recognition and large-scale structural analysis of the human bromodomain family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Structural Basis for Acetylated Histone H4 Recognition by the Human BRD2 Bromodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Bromodomains as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Place your BETs: the therapeutic potential of bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Selective recognition of acetylated histones by bromodomain proteins visualized in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Targeting MYC dependence in cancer by inhibiting BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

BET domain co-regulators in obesity, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Suppression of inflammation by a synthetic histone mimic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Brd4 associates with mitotic chromosomes throughout early zebrafish embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Reactivation of latent HIV-1 by inhibition of BRD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Selective inhibition of BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Epigenetic protein families: a new frontier for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Structures of the Dual Bromodomains of the P-TEFb-activating Protein Brd4 at Atomic Resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

A medicinal chemist's guide to molecular interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Progress in the discovery of small-molecule inhibitors of bromodomain--histone interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

A Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in Cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

The NCI60 human tumour cell line anticancer drug screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Drug-like properties and the causes of poor solubility and poor permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Molecular complexity and its impact on the probability of finding leads for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

A comparison of physiochemical property profiles of development and marketed oral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Quantifying the chemical beauty of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Ligand efficiency: a useful metric for lead selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

The influence of drug-like concepts on decision-making in medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Reaching for high-hanging fruit in drug discovery at protein-protein interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Ligand efficiency and fragment-based drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

Fragment-based lead discovery grows up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201307652

21 January 2018

Identifiers

DOI

10.1002/ANIE.201307652

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272870%20AND%20SRC:MED&resulttype=core&format=json